Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. Viewhere

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksE2V.L Regulatory News (E2V)

  • There is currently no data for E2V

Period end update

13 Oct 2011 07:00

RNS Number : 0892Q
e2v technologies PLC
13 October 2011
 



 

13 October 2011

 

e2v technologies plc

 

Period end update

 

e2v technologies plc, the specialist provider of technology solutions for high performance systems, is today providing this period end update for the six months ended 30 September 2011.

 

Current Year trading and outlook

 

Group trading for the first half is expected to be in line with management's expectations and ahead of the comparable period in the previous year. Underlying revenue grew by over 16%, with reported revenue growth of 9%. The difference largely reflects one off revenues of £6m.

 

The broader macro economic environment remains of concern and there are some signs of softening demand.

 

We continue to make good progress in executing our strategic plan and our outlook for the full year remains unchanged.

 

RF Power Solutions

 

The RF Power Solutions Division has three key applications: radiotherapy, electronic countermeasures and industrial processing.

 

- Strong growth over the comparable period in radiotherapy reflects steady OEM demand.

- As anticipated, European demand for electronic countermeasures (ECM) continues to be lower. We have secured an order for microwave power modules from a European OEM and are also making good progress with two US ECM programmes.

- In industrial processing systems, agreement has been reached for the first commercial field trial installation of our ProWave™ vermiculite processing system, which is due to be installed shortly. We have made good progress on our development programmes and have recently received a further order for an RF generator to support research into a new potential application in the mining sector.

- The remaining product lines in the division, which serve predominantly commercial and industrial markets, continue to perform well relative to the prior year and steadily on a sequential basis.

 

 

 

High Performance Imaging Solutions

 

The three key applications of this division are: machine vision, space imaging and scientific imaging.

 

- The machine vision sector delivered comparable underlying performance with the prior year, although this has shown some recent softness.

- Space imaging has delivered significant growth over the comparable period, reflecting the achievement of milestones on established programmes and progress on new projects. We have received an order for a focal array subsystem for a Korean land based telescope and have been selected to provide the camera for a ground based space science application in Brazil.

- Scientific imaging is also showing good growth arising from stronger end user demand.

- The remaining product lines in the division continue to show good underlying growth.

 

Hi-rel Semiconductor Solutions

 

This division addresses two main sectors: Semiconductor Lifecycle Management (SLiM™) and aerospace and defence semiconductors.

 

- The SLiM™ programme continues to benefit from the successful delivery within its existing programmes and a further four new defence programmes in Europe and the US have been added in the period, as well as the extension of the Raytheon F15 contract to cover further product lines. We also secured our first customer contract to provide extended product availability in collaboration with Maxim Semiconductors Inc.

- For the remaining product lines in the division we have seen improved demand for test and assembly services in Europe and the US compared to the prior year.

 

Order Book

 

Our total order book as at 30 September 2011 was £146m (30 September 2010 £167m), whilst our order book for delivery in the coming 12 months as at 30 September 2011 was £120m (30 September 2010 £147m). The reduction in the order book for delivery in the coming 12 months reflects a £7m reduction in the level of 'one-off' orders and the cycle of multiyear radiotherapy orders of £9m. We are also seeing a change in mix, as European defence activity (reduced by £2m) has been replaced with more commercial and industrial business with shorter order cycles.

 

 

 

Net Borrowings

 

Net borrowings at 30 September 2011 increased from 30 June 2011 by £4m to £32m, with operational cash performance in line with our expectations.

 

The group's new £80m revolving banking facility became effective 27 July 2011 and expires on 27 July 2015. As at 30 September 2011 the group had available £41m of undrawn committed borrowings from the facility.

 

The group remains in a sound financial position.

 

 

 

Keith Attwood, Chief Executive, said:

 

"The group has performed strongly in the first half. The changing order book profile reflects the anticipated change in the mix of our businesses.

 

The broader macro economic environment remains of concern and there are some signs of softening demand.

 

We continue to make good progress in executing our strategic plan. We are securing early orders for our industrial processing systems business and repositioning ourselves in the value chain for key applications such as space imaging and electronic counter measures.

 

Our outlook for the full year remains unchanged."

 

 

 

Further enquiries:

 

e2v technologies plc

Tel: +44 (0)1245 493 493

Keith Attwood, Chief Executive

Charles Hindson, Group Finance Director

Website: www.e2v.com

Pelham Bell Pottinger

Tel: +44 (0)20 7861 3232

Archie Berens

Clare Gilbey

 

 

Notes to editors

 

 

1. Net borrowings exclude capitalised borrowing costs.

 

2. All financial information included in this release is sourced from management accounts.

 

3. Statements made in this announcement that look forward in time or that express management's beliefs, expectations or estimates regarding future occurrences are "forward-looking statements" within the meaning of the United States federal securities laws. These forward-looking statements reflect the Group's current expectations concerning future events and actual results may differ materially from current expectations or historical results.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTMMMMGNZGGMZM
Date   Source Headline
5th Jul 20169:04 amRNSInvestor site visit and presentation
30th Jun 20162:09 pmRNSDirectorate Change
15th Jun 20169:25 amRNSAwards under Long Term Incentive Plan
13th Jun 20167:00 amRNS2016 Annual Report and Notice of AGM
7th Jun 20161:32 pmRNSDirector/PDMR Shareholding
6th Jun 20169:21 amRNSTotal Voting Rights
16th May 20167:00 amRNSFinal Results
6th May 201612:45 pmRNSTotal Voting Rights
19th Apr 201612:29 pmRNSChange of Director Details
15th Apr 201610:46 amRNSBlock Listing Return
4th Apr 20169:50 amRNSTotal Voting Rights
30th Mar 201610:47 amRNSHolding(s) in Company
7th Mar 201610:19 amRNSTotal Voting Rights
3rd Mar 20163:26 pmRNSDirectorate Change
23rd Feb 201611:35 amRNSDirector/PDMR Shareholding
18th Feb 20164:03 pmRNSHolding(s) in Company
17th Feb 201610:24 amRNSHolding(s) in Company
1st Feb 20169:46 amRNSTotal Voting Rights
26th Jan 20163:29 pmRNSHolding(s) in Company
25th Jan 20167:00 amRNSAcquisition and Q3 Trading Update
4th Jan 20169:10 amRNSTotal Voting Rights
11th Dec 20151:12 pmRNSBlock Listing Application
7th Dec 201510:39 amRNSTotal Voting Rights
30th Nov 20154:46 pmRNSHolding(s) in Company
13th Nov 20155:03 pmRNSHolding(s) in Company
11th Nov 20159:01 amRNSHolding(s) in Company
10th Nov 20159:21 amRNSHolding(s) in Company
2nd Nov 20157:00 amRNSHalf Yearly Report
9th Oct 20157:00 amRNSSale of Thermal Imaging Camera Systems
5th Oct 20158:52 amRNSTotal Voting Rights
23rd Sep 201512:45 pmRNSReplacement - Transaction in Own Shares
23rd Sep 201512:21 pmRNSTransaction in Own Shares
11th Sep 20156:09 pmRNSe2v technologies plc Transaction in Own Shares
10th Sep 20157:00 amRNSTransaction in Own Shares
9th Sep 20157:00 amRNSTransaction in Own Shares
8th Sep 20157:00 amRNSTotal Voting Rights
1st Sep 20152:53 pmRNSHolding(s) in Company
4th Aug 20159:00 amRNSTotal Voting Rights
15th Jul 20153:22 pmRNSResult of AGM
15th Jul 20157:00 amRNSAGM Trading Update
9th Jul 20154:34 pmRNSBlock listing Application
8th Jul 20151:03 pmRNSHolding(s) in Company
6th Jul 20159:41 amRNSTotal Voting Rights
25th Jun 20152:53 pmRNSDirector/PDMR Shareholding
15th Jun 20159:49 amRNSAnnual Report, Financial Statement & Notice of AGM
12th Jun 20155:01 pmRNSHolding(s) in Company
1st Jun 201511:33 amRNSTR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES
18th May 20157:00 amRNSFinal Results
8th May 20152:59 pmRNSTotal Voting Rights
16th Apr 20157:00 amRNSFull Year 2015 Trading Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.